The North American sleep-wake disorder market is estimated to grow at a CAGR of 5.9% during the forecast period. The growth of the sleep-wake disorder market in North America is attributed to the well-established healthcare infrastructure, rise in awareness among people, and an increase in the prevalence of sleep disorders. As per the World Bank, the aging population of the US was around 52.3 million and Canada was around 6 million in 2018. The geriatric population is more prone to sleep-wake disorders. In addition, the presence of major market players, especially in the US including ResMed Inc., Neurocrine Biosciences, Inc., and others further supports the growth of the sleep-wake disorder market in the region during the forecast period.
To Request a Sample of our Report on North American Sleep-Wake Disorder Market: https://www.omrglobal.com/request-sample/north-american-sleep-wake-disorder-market
The market is segmented on the basis of type and treatment. Based on type, the market is sub-segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm disorders, and others. Sleep apnea holds the largest market share during the forecast period. On the basis of treatment, the market is divide into therapies, drugs, and devices. The sleep-wake disorder devices segment is estimated to hold the largest market share during the forecast period, followed by medications.
(Get 15% Discount on Buying this Report)
A full Report of North American Sleep-Wake Disorder Market is Available at: https://www.omrglobal.com/industry-reports/north-american-sleep-wake-disorder-market
North American Sleep-Wake Disorder Market Segmentation
By Type
· Insomnia
· Hypersomnia
· Circadian Rhythm Disorders
· Others
By Treatment
· Therapies
· Drugs
· Devices
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
